News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Scientific Corporation (BSX) Wins Patent Infringement Case Against Johnson & Johnson (JNJ) In The Netherlands



10/19/2005 5:08:52 PM

NATICK, Mass., June 9 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson , infringes a Boston Scientific balloon catheter patent. The following catheter products were found to infringe: the CYPHER(R) RAPTOR(TM), the CYPHER SELECT(TM), the Bx VELOCITY(R) RAPTOR(TM), the Bx SONIC(TM), the U-Pass, and the AQUA T3(TM). The court's decision gives Boston Scientific the right to damages and to an injunction against Cordis' manufacturing, using, or selling the infringing catheters in the Netherlands.

"We are very pleased with the decision. It confirms our belief that Boston Scientific is at the forefront of innovation and has fundamental intellectual property in the treatment of coronary artery disease," said Paul LaViolette, Boston Scientific's Chief Operating Officer. "We are hopeful that it will provide an opportunity for a fair and reasonable settlement of the numerous disputes between our two companies."

Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

This press release contains forward-looking statements. The Company wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with litigation and other factors described in the Company's filings with the Securities and Exchange Commission.

CONTACT: Milan Kofol 508-650-8569 Investor Relations Boston Scientific Corporation Paul Donovan 508-650-8541 Media Relations Boston Scientific Corporation

Boston Scientific Corporation

CONTACT: Milan Kofol, +1-508-650-8569, Investor Relations, or PaulDonovan, +1-508-650-8541, Media Relations, both of Boston ScientificCorporation


Read at BioSpace.com
Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES